Overview
- 4 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-09-16.
At a glance
Inspections
4
Form 483s
3
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 8 Sep 2025 – 16 Sep 2025 | Human Drugs | WL | On file |
| 15 Jan 2024 – 24 Jan 2024 | Human Drugs | 483 | On file |
| 10 Jan 2023 – 20 Jan 2023 | Human Drugs | WL | View 483 → |
| 8 Apr 2019 – 12 Apr 2019 | Human Drugs | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
20 Jan 2023
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Arsen Karapetyan, Teresa I Navas
20 Jan 2023
21 CFR 211.113(a)
Procedures for non-sterile drug products
Cited by Arsen Karapetyan, Teresa I Navas
20 Jan 2023
21 CFR 211.113(b)
Procedures for sterile drug products
Cited by Arsen Karapetyan, Teresa I Navas
20 Jan 2023
21 CFR 211.192
Written record of investigation incomplete
Cited by Arsen Karapetyan, Teresa I Navas
20 Jan 2023
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Arsen Karapetyan, Teresa I Navas
Investigators
FDA investigators tied to this site in the record.
Tamil Arasu2 insp.
Saleem A Akhtar1 insp.
Jeffrey P Raimondi1 insp.
Patty P Kaewussdangkul1 insp.
Arsen Karapetyan1 insp.
Teresa I Navas1 insp.
Jason R Caballero1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Intas Pharmaceuticals Ltd.'s 3 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat